Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Date of authorisation: 15/07/1998, Revision: 53, Status: Authorised

PSUSA/00000699/202411

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 13, Status: Authorised

PSUSA/00009247/202411

PSUSA/00001021/202411

IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants

Human medicines European public assessment report (EPAR): Axumin, fluciclovine (18F), Date of authorisation: 21/05/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised